These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6124265)

  • 61. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 62. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Labetalol and bendrofluazide: comparison of their antihypertensive effects.
    Horvath JS; Caterson RJ; Collett P; Duggin GG; Kelly DH; Tiller DJ
    Med J Aust; 1979 Jun; 1(13):626-8. PubMed ID: 386062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.
    Dawson A; Johnson BF; Smith IK; Munro-Faure AD
    Br J Clin Pharmacol; 1979 Aug; 8(2):149-54. PubMed ID: 385023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intravenous labetalol in hypertensive patients given by fast and slow injection.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1978 May; 5(5):401-5. PubMed ID: 350248
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ; Kalowski S; Guest C
    Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid onset of action of oral labetalol in severe hypertension.
    Ghose RR; Sampson A
    Curr Med Res Opin; 1977; 5(2):147-51. PubMed ID: 340130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
    Dent R; Kellaway GS
    N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation of noradrenergic transmission by the presynaptic alpha-inhibitory feedback process in the rat heart [proceedings].
    Drew GM
    Br J Pharmacol; 1978 Mar; 62(3):381P-382P. PubMed ID: 205296
    [No Abstract]   [Full Text] [Related]  

  • 71. Intravenous labetalol in hypertensive emergency.
    Cumming AM; Davies DL
    Lancet; 1979 Apr; 1(8122):929-30. PubMed ID: 86702
    [No Abstract]   [Full Text] [Related]  

  • 72. Labetalol in hypertension.
    Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
    [No Abstract]   [Full Text] [Related]  

  • 73. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 74. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
    Hansson L; Hänel B
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):729-32. PubMed ID: 10951
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.